| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Andreas Wicki last filed a Form 4 in December 2022, as Director at HRMY. The filings on record cover 2 companies. From November 2018 to December 2022, the filings on record show 0 open-market purchases and 20 sales. Andreas Wicki's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Andreas Wicki a strong insider score of 71/100, based on 33 past trades. Over a 12-month horizon, 75.8% of those trades were profitable, with an average 12-month return of +20.0%.
At the last filing, the largest reported position was 2,147,943 shares of HRMY. The HRMY filings lean toward selling, a net 2,493,836 shares.
Shares as reported in the last Form 4 for each company; the most recent is from December 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2021 | HRMY Harmony Biosciences Holdings, Inc. | Director | Sell | 69,268 | $41.60 | $2,881,692.84 | -1.5% | -0.9% | +39.7% | |
| Mar 15, 2021 | PCRX Pacira Biosciences, Inc. | Director | Sell | 69,355 | $73.19 | $5,075,999.08 | -13.3% | -17.2% | -2.6% | |
| Mar 11, 2021 | PCRX Pacira Biosciences, Inc. | Director | Sell | 172,191 | $71.92 | $12,384,677.50 | -24.9% | -15.9% | -2.0% | |
| Sep 9, 2020 | PCRX Pacira Biosciences, Inc. | Director | Sell | 2,216 | $62.02 | $137,436.32 | -0.3% | - | - | |
| Aug 13, 2020 | PCRX Pacira Biosciences, Inc. | Director | Sell | 255,176 | $61.12 | $15,595,366.05 | -26.9% | - | - | |
| Dec 13, 2018 | PCRX Pacira Biosciences, Inc. | Director | Sell | 14,527 | $46.84 | $680,495.61 | -1.5% | - | - | |
| Nov 19, 2018 | PCRX Pacira Biosciences, Inc. | Director | Sell | 990 | $47.08 | $46,605.34 | -0.1% | - | - | |
| Nov 16, 2018 | PCRX Pacira Biosciences, Inc. | Director | Sell | 70,498 | $47.34 | $3,337,586.90 | -6.8% | - | - | |
| Nov 12, 2018 | PCRX Pacira Biosciences, Inc. | Director | Sell | 5,478 | $49.83 | $272,980.24 | -0.5% | - | - | |
| Nov 9, 2018 | PCRX Pacira Biosciences, Inc. | Director | Sell | 58,245 | $51.11 | $2,977,090.72 | -5.3% | - | - |